Carvolix SA (EPA:CVX)

France flag France · Delayed Price · Currency is EUR
2.860
-0.090 (-3.05%)
Apr 28, 2026, 5:35 PM CET
115.04%
Market Cap 169.44M
Revenue (ttm) 900.00K
Net Income (ttm) -24.97M
Shares Out 59.24M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,054
Average Volume 14,865
Open 2.950
Previous Close 2.950
Day's Range 2.690 - 2.950
52-Week Range 1.160 - 5.220
Beta 1.06
RSI 40.64
Earnings Date Apr 24, 2026

About Carvolix

Carvolix SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was formerly known as Affluent Medical SA and changed its name to Carvolix SA in February 20... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2011
Employees 68
Stock Exchange Euronext Paris
Ticker Symbol CVX
Full Company Profile

Financial Performance

In 2025, Carvolix's revenue was 900,000, a decrease of -83.18% compared to the previous year's 5.35 million. Losses were -24.97 million, 69.4% more than in 2024.

Financial Statements

News

There is no news available yet.